CN103974964B - β-C-芳基葡糖苷的制备方法 - Google Patents

β-C-芳基葡糖苷的制备方法 Download PDF

Info

Publication number
CN103974964B
CN103974964B CN201280054691.2A CN201280054691A CN103974964B CN 103974964 B CN103974964 B CN 103974964B CN 201280054691 A CN201280054691 A CN 201280054691A CN 103974964 B CN103974964 B CN 103974964B
Authority
CN
China
Prior art keywords
formula
compound
aryl
arylation
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201280054691.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN103974964A (zh
Inventor
朱利安·保罗·亨施克
林振玮
吴平宇
萧志农
廖志雄
萧宗育
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scinopharm Taiwan Ltd
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of CN103974964A publication Critical patent/CN103974964A/zh
Application granted granted Critical
Publication of CN103974964B publication Critical patent/CN103974964B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CN201280054691.2A 2011-11-07 2012-11-07 β-C-芳基葡糖苷的制备方法 Expired - Fee Related CN103974964B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161556780P 2011-11-07 2011-11-07
US61/556,780 2011-11-07
US201261661793P 2012-06-19 2012-06-19
US61/661,793 2012-06-19
PCT/IB2012/002894 WO2013068850A2 (en) 2011-11-07 2012-11-07 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES

Publications (2)

Publication Number Publication Date
CN103974964A CN103974964A (zh) 2014-08-06
CN103974964B true CN103974964B (zh) 2016-03-23

Family

ID=48290709

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280054691.2A Expired - Fee Related CN103974964B (zh) 2011-11-07 2012-11-07 β-C-芳基葡糖苷的制备方法

Country Status (11)

Country Link
EP (1) EP2776449B1 (en:Method)
JP (1) JP6144686B2 (en:Method)
KR (1) KR101756772B1 (en:Method)
CN (1) CN103974964B (en:Method)
AU (1) AU2012335280B2 (en:Method)
BR (1) BR112014010997A2 (en:Method)
CA (1) CA2854591A1 (en:Method)
IL (1) IL232418A (en:Method)
IN (1) IN2014CN04050A (en:Method)
TW (1) TWI488861B (en:Method)
WO (1) WO2013068850A2 (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557894A (zh) * 2013-10-18 2015-04-29 上海信谊药厂有限公司 坎格列汀晶型及其制备方法
WO2015155739A1 (en) * 2014-04-11 2015-10-15 Scinopharm Taiwan, Ltd. Process for the preparation of beta-c-arylglucosides
CN105017237A (zh) * 2014-04-29 2015-11-04 嘉实(湖南)医药科技有限公司 一种卡格列净的制备工艺
EP2947077A1 (en) 2014-05-19 2015-11-25 LEK Pharmaceuticals d.d. Stereoselective synthesis of intermediates in the preparation of ß-C-arylglucosides
US10370365B2 (en) 2015-09-16 2019-08-06 Optimus Drugs (P) Limited Process for the preparation of Canagliflozin
CN105294624B (zh) * 2015-11-16 2018-01-12 山东罗欣药业集团股份有限公司 一种达格列净的制备方法
CN105486767B (zh) * 2015-12-03 2018-03-13 上海应用技术学院 一种达格列净及其α‑异构体的分离方法
CN105541815B (zh) * 2015-12-24 2018-07-13 寿光富康制药有限公司 一种卡格列净的制备方法
WO2021176096A1 (en) 2020-03-05 2021-09-10 Krka, D.D., Novo Mesto Pharmaceutical composition comprising sglt2 inhibitor
CN115867538A (zh) 2020-06-05 2023-03-28 新梅斯托克公司 高纯的无定形达格列净的制备

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031548A2 (en) * 2005-09-15 2007-03-22 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5872599A (ja) * 1981-10-27 1983-04-30 Kanto Ishi Pharma Co Ltd 複合糖質誘導体
CN101260130A (zh) * 2003-01-03 2008-09-10 布里斯托尔-迈尔斯斯奎布公司 制备c-芳基葡糖苷sglt2抑制剂的方法
CN102762583A (zh) * 2009-11-24 2012-10-31 南非医学研究院 合成阿司巴汀及其类似物的方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031548A2 (en) * 2005-09-15 2007-03-22 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof

Also Published As

Publication number Publication date
BR112014010997A2 (pt) 2017-06-06
IL232418A0 (en) 2014-06-30
IL232418A (en) 2016-10-31
TWI488861B (zh) 2015-06-21
WO2013068850A3 (en) 2013-08-22
WO2013068850A8 (en) 2013-10-10
AU2012335280A1 (en) 2014-05-22
KR101756772B1 (ko) 2017-07-26
CN103974964A (zh) 2014-08-06
KR20140089427A (ko) 2014-07-14
TW201335175A (zh) 2013-09-01
JP2014532690A (ja) 2014-12-08
EP2776449B1 (en) 2017-08-02
WO2013068850A2 (en) 2013-05-16
JP6144686B2 (ja) 2017-06-07
CA2854591A1 (en) 2013-05-16
EP2776449A2 (en) 2014-09-17
AU2012335280B2 (en) 2016-09-29
EP2776449A4 (en) 2015-10-07
IN2014CN04050A (en:Method) 2015-07-10

Similar Documents

Publication Publication Date Title
CN103974964B (zh) β-C-芳基葡糖苷的制备方法
JP4834080B2 (ja) グルコピラノシル置換ベンジル−ベンゼン誘導体の調製方法及びこれらの方法における中間体
CN101103013B (zh) 1-硫代-d-葡萄糖醇衍生物
TWI254635B (en) Azulene derivative and salt thereof
CN102574829B (zh) 吡喃葡萄糖基取代的苄基-苯衍生物的制备方法
US8952139B2 (en) Process for the preparation of β-C-aryl glucosides
CN101495495A (zh) 取代螺缩酮衍生物、及其作为糖尿病治疗药的应用
CN101111492A (zh) 吲哚衍生物
CN107163092A (zh) Sglt‑2糖尿病抑制剂及其中间体的制备方法
EP2676965A1 (en) Aryl glycoside compound, preparation method and use thereof
WO2015181692A1 (en) Process for preparation of canagliflozin
TW202039428A (zh) C-芳基羥基二醇化物(C-Arylhydroxyglycoxide)衍生物之製造方法
CN101475615B (zh) 氨基酸糖类化合物及其用途
CN104327027B (zh) 一类新型c‑芳基葡萄糖苷sglt2抑制剂
CN109096270A (zh) 一种卡格列净4-位异构体杂质及其制备方法
CN108341739B (zh) 一种α-芳基、杂芳基或烯基-α,α-二氟甲基类化合物的制备方法
CN109553649B (zh) 一种卡格列净中间体的制备方法
CN1724551A (zh) 一种α-熊果苷的制备方法
HK1188602A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
HK1112239B (en) 1-thio-d-glucitol derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160323

Termination date: 20181107

CF01 Termination of patent right due to non-payment of annual fee